Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only?

Current Opinion in Urology

Volumn 14, Issue 1, 2004, Pages 27-29

  Anson, Ken ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Benign prostatic hyperplasia (BPH); Laser surgery; Potassium titanyl phosphate (KTP) laser; Transurethral resection of the prostate (TURP)

Indexed keywords

BLOOD CLOTTING; CATHETERIZATION; CONVALESCENCE; EVOLUTION; HUMAN; LASER; LASER SURGERY; OPERATION DURATION; POTASSIUM TITANYL PHOSPHATE LASER; PRIORITY JOURNAL; PROSTATE; PROSTATECTOMY; REVIEW; SAFETY; SURGICAL APPROACH; SURGICAL RISK; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; VAPORIZATION; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; FOLLOW UP; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PROSTATE HYPERTROPHY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; URODYNAMICS;

AGED; CLINICAL TRIALS; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URODYNAMICS;

EID: 2342526517     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200401000-00006     Document Type: Review

References (20)

1. Hakenberg O, Pinnock C, Marshall V. Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome. BJU Int 2003; 91:375-379
2. Neal D, Ramsden P, Sharples L, et al. Outcome of elective prostatectomy. BMJ 1989; 299:762-767.
3. Anson K, Nawrocki J, Buckley J, et al. A multicentre, randomised, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46:305-310.
4. Van Melick HHE, Van Venrooij GEPM, Eckhardt MD, Boon TA. A randomised controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporisation in men with benign prostatic hyperplasia:urodynamic effects. J Urol 2002; 168:1058-1062.
5. Keoghane S, Lawrence K, Gray A, et al. A double-blind randomised controlled trial and economic evaluation of transurethral resection vs contact laser vaporisation for benign prostatic enlargement: a 3 year follow-up. BJU Int 2000; 85:74-78.
6. Horninger W, Volgger H, Strohmeyer D, et al. Long term results of TULIP, interstitial laser and contact laser surgery [abstract]. Eur Urol 2002; (Suppl 1):660.
7. Fraundorfer M. Kennet K. Gilling P. Holmium laser enucleation of the prostate (HoLEP) combined with intravesical tissue morcellation [abstract]. BJU Int 1999; 83 (Suppl 4):6.
8. Tan A, Gilling P, Kennett K, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 Grams). J Urol 2003; 170:1270-1274. This was a useful study by the doyen of holmium laser enucleation of the prostate comparing it with TURP in large prostates.
9. Carter A, O'Boyle P. First clinical experience of high power KTP lasers in the treatment of BPH [abstract]. Br J Urol 1997; 80 (Suppl 2):199.
10. Shingleton WB, Farabough P, May W. Three year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyerplasia. Urology 2002; 60:305-308.
11. Abdel-Khalek M, El-Hammady S, Ibrahiem El-H. A four year follow-up of a randomised prospective study comparing transurethral electrovaporisation of the prostate with neodymium:YAG laser therapy for treating benign prostatic hyerplasia. BJU Int 2003; 91:801-805.
12. Malek R, Kuntzman R, Barrett D. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000; 163:1730-1733.
13. Hai M, Malek RS. Photoselective vaporisation of the prostate: Initial experience with a new 80watt KTP laser for the treatment of benign prostatic hyperplasia. J Endourol 2003; 17:93-96. This paper describes the evolution of PVP and the early clinical experience with the high power technique.
14. Malek R, Kuntzman R. Photoselective vaporisation of the prostate: 5 year experience with high power KTP laser [abstract]. J Urol 2003; 169:4 (Suppl):1457.
15. Sandhu J, Vanderbrink B, Egan C, et al. High-power KTP photoselective laser vaporisation prostatectomy for the treatment of benign prostatic hyperplasia in men with large prostates [abstract]. J Urol 2003; 169:4 (Suppl):1470.
16. Te A, Malloy T, Stein B, et al. Photoselective laser vaporisation of the prostate (PVP) for treatment of benign prostatic hyperplasia (BPH): the first multicentre prospective trial [abstract]. J Urol 2003; 169:4 (Suppl):1745.
17. Kleeman M, Nseyu U. KTP laser selective vaporisation of the prostate in the management of acute urinary retention due to BPH. Society of Photo-Optical Instrument Engineers 2003; 4949:68-72.
18. Aho T, Gilling P. Laser therapy for benign prostatic hyperplasia: a review of recent developments. Curr Opin Urol 2003; 13:39-44.
19. Hoffman R, MacDonald R, Slaton J, et al. Laser prostatectomy versus transurethral resection for treating benign prostatic obstructions systematic review. J Urol 2003; 169:210-215. This is an excellent review comparing all the important laser versus TURP trials. It ties together all the various laser techniques in an easy-to-understand manner.
20. Chander J, Vanitha V, Lal P, et al. Transurethral resection of the prostate as catheter-free day-care surgery. BJU Int 2003; 92:422-425.